-
ALEX BODI și SCANDIC PAY: Parteneriat internațional pentru o generație cu adevărat nouă de plăți
-
Maswanganyi Clarifies Pirates Allegiance Amidst Career Transition
-
Search Underway for 'Dooars Rani' Tigress After Second Escape from Buxa Tiger Reserve
-
Teatro Mayor Unveils 152-Performance 2027 Season Highlighting Beethoven and García Márquez
-
The Dilemma of Recording Live Music: Preserving Memories vs. Being Present
-
Rutgers Defeats NJIT 101-64 Behind Francis and Mark Scores
-
XCF Global Hosts USDA at New Rise Renewables Reno as Facility Surpasses 4.4 Million Gallons Since Restart
-
Marketing Worldwide Corporation (OTC:MWWC) Announces 1-for-350 Reverse Stock Split Effective November 11, 2026
-
Valion Bio Reinforces Commitment to American Troops; Discusses Entolimod with Attendees at RW Baird's National Security Conference
-
Green Leaf Innovations (OTC: GRLF) Meets OTCID Disclosure Requirements Following Profitable Q2 2026 Results
-
PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
-
Ethur Takes On Hiring Fraud With Facial Biometrics Identity Checks and Connected Payroll and Bank Data
-
NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
-
Route1 Announces 2026 Annual Meeting Results
-
Healixa's FrostPulse(TM) Technology Solves a Major Roadblock to Data Center Growth: Cooling Without the Water Burden
-
Protagenic Therapeutics Announces Private Placement of Up to $5 Million to Advance PT00114 into Its First U.S. Clinical Trial in Generalized Anxiety Disorder
-
Patriot Software Adds Performance Reviews to Patriot HR
-
5E Advanced Materials to Host Fiscal First Quarter 2027 Earnings Conference Call on November 17, 2026
-
Aptevo Therapeutics Announces Exercise of Existing Warrants for $3.0 Million Gross Proceeds
-
Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets
-
AmeriLife Welcomes Finance Veteran Richard Dziadzio as Chief Financial Officer; Names Jim Quinn President & Chief Transformation Officer
-
Trifecta Gold Reports 2026 Exploration Results from the Liam and Lois Projects, Tombstone Gold Belt, Yukon
-
Irving Resources Reports on Drilling in Yamagano Mining Right at the Yamagano Joint Venture, Kyushu, Japan
-
NiobiumX Mining Reports Results of Ground Radiometric Survey at Shipshaw, Maps Two Distinct Radiometric Signatures Across the Core Claims, and Moves to a High-Resolution Airborne Survey of the Full 2,686-Hectare Package
-
BlackBerry to Participate in Upcoming Investor Conferences
-
Christmas Day Shifts More than Double as Americans Return to In-Person Holiday Celebrations
-
THIEAUDIO Introduces Clairvoyance MKII: The Evolution of a Signature Sound
-
Fulcrum Metals PLC Announces Publication of Updated Investor Presentation
-
Guardian Metal Resources PLC Announces Proposed Spin-Out of Non-Tungsten Projects
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 11
-
Fulcrum Metals PLC Announces New Critical Mineral Recoveries Expand Potential
-
6 Pieces of Furniture Worth Investing In
-
Healthcare Leaders Identify Priorities for Agentic AI Adoption in 2027-2028 - Black Book
-
Lion Copper Corp. Completes S-K 1300 Technical Report Summary for Bear Copper Deposit
-
American Rebel Holdings, Inc. (OTCID: AREB) Honors Veterans Across America
-
LogoTags, America's Leading Name in Custom Challenge Coins, Showcased at Kentucky Officers Leadership Symposium
-
SMX Advances AI Technology to Bring Greater Precision to Industrial Material Development
-
TripGift Unlocks Millions of Travel and Live Event Experiences for Corporate Rewards and Incentives in 117 Currencies
-
Leiər Introduces Passport, a New Fragrance Collection Debuting With Alba Eau De Parfum
-
WhalesBot Emphasizes Child Safety and Responsible AI Design in the Development of Pubbo
-
SMX Bridges AI and Industrial Material Science With New Intelligence Platform
-
Moderna Announces JAMA Network Open Publication of Real-World Comparative Effectiveness Data for mNEXSPIKE (COVID-19 Vaccine, mRNA) in Adults Aged 65 Years and Older
-
Sequoia Backs Microsoft Veterans' Edelbyte with $70M to Challenge Data Infrastructure Giants
-
Price Benowitz Earns 2027 Best Law Firm Recognition; 18 Attorneys Recognized by Best Lawyers
-
DaBella Honors More Than 200 Veteran Employees Nationwide This Veterans Day
-
ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
-
Resilient Energy Inc. (OTCID:RENI) Closes Acquisition of Mid River Midstream; Adds 12 Texas SWD Wells and $25M in Assets
-
SMX Expands Technology Portfolio With AI-Powered Scientific Intelligence Platform
-
LA Kush Cake Strain Guide Reviews Genetics and Historical Potency Data
-
Solid Aluminum, Deep Thock and 75% Compact Layout: Meet the Epomaker Galaxy75 Mechanical Keyboard
Discovering HIV started 'race against time': Barre-Sinoussi
When Nobel laureate Francoise Barre-Sinoussi helped identify a mysterious virus that would become known as HIV 40 years ago, she says it kicked off a "race against time" to counter the looming AIDS crisis.
In an interview with AFP, the 75-year-old virologist described how she and colleagues at the Pasteur Institute in Paris discovered HIV in 1983, which led to her jointly winning the Nobel Prize for Medicine.
"It all started in 1982," when doctors started sharing stories about the first French AIDS patients, France's Barre-Sinoussi said.
"They were convinced that a retrovirus could be responsible for this new disease."
For more than a decade Barre-Sinoussi had been working on retroviruses, which on infection convert from the genetic material RNA into DNA, allowing them to easily integrate host cells.
In January 1983, the team's strategy was to take a lymph node biopsy from a sick patient, then culture the cells in the lab looking for "very specific enzymatic activity", she said.
Her French doctor colleagues thought that AIDS must be caused by HTLV-1, the only retrovirus known to directly cause cancer in humans.
"But our team did not believe in this hypothesis because this virus causes a proliferation of lymphocytes," Barre-Sinoussi said.
AIDS patients had lower rates of this important immune cell.
"Something didn't add up," she said.
"In May 1983, we isolated the virus and demonstrated that it was a retrovirus that was different from HTLV-1. But we were not yet certain that it caused AIDS."
That was confirmed the following year by US scientist Robert Gallo.
This caused a transatlantic rift over who discovered HIV, with the United States and France eventually agreeing that both Gallo and the Pasteur team led by Luc Montagnier should get joint credit.
- 'Enormous' challenge ahead -
Finally, researchers around the world had a target to aim for in their efforts to combat AIDS, which was rapidly spreading and devastating communities.
"From then on, the task was enormous because we were faced with an unknown virus," Barre-Sinoussi said.
"We had to learn everything about it, find out what proteins it contained, its genetic material, what type of cells it infected, the consequences of this infection."
A crucial first step was to develop tests as quickly as possible, both to diagnose patients and to demonstrate that HIV only infected AIDS patients.
"Only then could strategies be considered to try to block it," she said.
"It was a race against time because we realised that the virus was transmitted by blood, sex and from mother to child."
The endeavour required the swift mobilisation of immunologists, molecular biologists and doctors, she said.
Not to mention patients, even though scientists knew "we would not have time to find a treatment that could save them", she said.
"We found ourselves faced with people who came to the Pasteur Institute to ask us questions about the virus," she said.
"It was very difficult."
- Nobel 'recognised a community' -
In 2008, Barre-Sinoussi and her former mentor, Luc Montagnier, jointly received the Nobel medicine prize for the discovery of HIV.
"I was in Cambodia when I heard the news. It was a huge surprise. I did not expect it all," Barre-Sinoussi said.
"People living with HIV in the country came up to me with smiles and bouquets of flowers.
"I understood that this prize recognised a community that had been working together from the beginning."
"All levels of society have been affected by HIV/AIDS, which has always been a battle on multiple fronts -- scientific of course, but also political, societal (and) against pharmaceutical companies," she said.
When she started her career, "I was a researcher who never left the laboratory", she said.
But after helping discover HIV, things changed. "I suddenly found myself faced with things that I never imagined possible, such as the general public's lack of tolerance towards certain people," she said.
"Patients were stigmatised, abandoned by their families, their friends, sometimes by health professionals. Some lost their homes, their jobs."
Barre-Sinoussi said that she had also "learned a lot about inequalities, which unfortunately may have become even worse today".
Throughout her long career, Barre-Sinoussi worked continuously towards finding a cure for HIV, serving as the president of the International AIDS Society a decade ago. She retired in 2017.
P.Costa--AMWN